Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Natural Resources, for a period to be subsequently determined by the Spe…
The bill (HEARD Act of 2025) directs the Department of Health and Human Services and NIH to expand, coordinate, and prioritize research on rare diseases that disproportionately affect minority populations. It creates an NIH coordinating committee, requires a Federal research and education plan, funds grants for data collection, training, mentoring, scholarships, loan repayment, and tribal epidemiology centers, mandates CDC awareness campaigns, directs an FDA survey on clinical trial diversity, and requires Medicare and HHS reports to Congress.
Funding certainty: liberals assume needed funds; conservatives demand cost estimates
Programmatic health research bills often attract bipartisan support; requires appropriations and committee approval.
The bill (HEARD Act of 2025) directs the Department of Health and Human Services and NIH to expand, coordinate, and prioritize research on rare diseases that disproportionately affect minority populations.
It creates an NIH coordinating committee, requires a Federal research and education plan, funds grants for data collection, training, mentoring, scholarships, loan repayment, and tribal epidemiology centers, mandates CDC awareness campaigns, directs an FDA survey on clinical trial diversity, and requires Medicare and HHS reports to Congress.
Several deadlines are specified (plans within 1 year, reports within 2 years, some actions within 180 days).
Technocratic, narrowly targeted research measures increase chances, but funding needs, political sensitivity about 'equity', and procedural hurdles temper likelihood.
How solid the drafting looks.
Funding certainty: liberals assume needed funds; conservatives demand cost estimates
These are examples from the analysis, not a ranked list of the most-affected groups.
Funding certainty: liberals assume needed funds; conservatives demand cost estimates
Likely strongly supportive: the bill targets health inequities, increases research on neglected populations, and funds workforce diversity and tribal programs.
It aligns with progressive priorities on equity, representation, and targeted public investment.
Some impact depends on future appropriations and program design, which is uncertain.
Generally favorable but cautious: the bill addresses clear data and workforce gaps and could improve care for underserved patients.
A centrist will want clearer funding, performance metrics, and avoidance of duplicative programs.
Support depends on cost information and implementation details.
Likely skeptical: the bill expands federal coordination, grant programs, and incentives, raising concerns about new bureaucracy, taxpayer costs, and regulatory pressure on drug development.
However, targeted support for tribal health and telehealth could be viewed positively if limited and efficient.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Technocratic, narrowly targeted research measures increase chances, but funding needs, political sensitivity about 'equity', and procedural hurdles temper likelihood.
The bill has not accumulated any surfaced votes yet.
Funding certainty: liberals assume needed funds; conservatives demand cost estimates
Technocratic, narrowly targeted research measures increase chances, but funding needs, political sensitivity about 'equity', and procedural…
Pro readers get the full perspective split, passage barriers, legislative design review, stakeholder impact map, and lens-based policy tradeoff analysis for HEARD Act of 2025.
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.